| 1 | 21607291 | A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock. | Mol Med | 2011 Sep-Oct |
2 |
| 2 | 22827443 | Treatment of mild traumatic brain injury with an erythropoietin-mimetic peptide. | J Neurotrauma | 2013 May 1 |
1 |
| 3 | 23168581 | Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study. | Mol Med | 2012 Nov 15 |
1 |
| 4 | 23262243 | The erythropoietin-derived peptide ARA290 reverses mechanical allodynia in the neuritis model. | Neuroscience | 2013 Mar 13 |
2 |
| 5 | 23302512 | ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injury. | J Transl Med | 2013 Jan 9 |
4 |
| 6 | 23936499 | Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131). | PLoS One | 2013 |
1 |
| 7 | 24225194 | Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injury. | J Transl Med | 2013 Nov 13 |
3 |
| 8 | 24518674 | Therapeutic effects of nonerythropoietic erythropoietin analog ARA290 in experimental autoimmune encephalomyelitis rat. | J Neuroimmunol | 2014 Mar 15 |
3 |
| 9 | 24529189 | ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response. | Mol Pain | 2014 Feb 16 |
2 |
| 10 | 25373867 | Modulation of cellular stress response via the erythropoietin/CD131 heteroreceptor complex in mouse mesenchymal-derived cells. | J Mol Med (Berl) | 2015 Feb |
7 |
| 11 | 26431906 | Testing the antidepressant properties of the peptide ARA290 in a human neuropsychological model of drug action. | Eur Neuropsychopharmacol | 2015 Dec |
1 |
| 12 | 26459940 | Nonerythropoietic Erythropoietin-Derived Peptide Suppresses Adipogenesis, Inflammation, Obesity and Insulin Resistance. | Sci Rep | 2015 Oct 13 |
4 |
| 13 | 26774587 | ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception. | Peptides | 2016 Feb |
1 |
| 14 | 27172159 | ARA290, a Specific Agonist of Erythropoietin/CD131 Heteroreceptor, Improves Circulating Endothelial Progenitors' Angiogenic Potential and Homing Ability. | Shock | 2016 Oct |
2 |
| 15 | 29026145 | Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis. | Sci Rep | 2017 Oct 12 |
4 |
| 16 | 29223734 | Activation of the EPOR-β common receptor complex by cibinetide ameliorates impaired wound healing in mice with genetic diabetes. | Biochim Biophys Acta Mol Basis Dis | 2018 Feb |
2 |
| 17 | 29392190 | Targeting the innate repair receptor to treat neuropathy. | Pain Rep | 2016 Jul |
1 |
| 18 | 29880388 | EPO Derivative ARA290 Attenuates Early Renal Allograft Injury in Rats by Targeting NF-κB Pathway. | Transplant Proc | 2018 Jun |
1 |
| 19 | 30876881 | The vasoreparative potential of endothelial colony-forming cells in the ischemic retina is enhanced by cibinetide, a non-hematopoietic erythropoietin mimetic. | Exp Eye Res | 2019 May |
7 |
| 20 | 32171100 | Technetium-99 m-PEGylated dendrimer-G<sub>2</sub>-(Dabcyle-Lys<sup>6</sup>,Phe<sup>7</sup>)-pHBSP: A novel Nano-Radiotracer for molecular and early detecting of cardiac ischemic region. | Bioorg Chem | 2020 May |
2 |
| 21 | 32335150 | An engineered non-erythropoietic erythropoietin-derived peptide, ARA290, attenuates doxorubicin induced genotoxicity and oxidative stress. | Toxicol In Vitro | 2020 Aug |
1 |
| 22 | 34478930 | Multifaceted roles of a bioengineered nanoreactor in repressing radiation-induced lung injury. | Biomaterials | 2021 Oct |
1 |
| 23 | 34498509 | Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation. | Cell Transplant | 2021 Jan-Dec |
5 |